Common polymorphisms in MIR146a, MIR128a and MIR27a genes contribute to neuropathy susceptibility in type 2 diabetes

Acta Diabetologica

Volumn 51, Issue 4, 2014, Pages 663-671

  Ciccacci, Cinzia ^a   Morganti, Roberto ^a   Di Fusco, Davide ^a   D'Amato, Cinzia ^a   Cacciotti, Laura ^a   Greco, Carla ^a   Rufini, Sara ^a   Novelli, Giuseppe ^a   Sangiuolo, Federica ^a   Marfia, Girolama A ^a   Borgiani, Paola ^a   Spallone, Vincenza ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Autonomic neuropathy; Diabetic neuropathy; microRNAs; Single nucleotide polymorphisms (SNPs); Type 2 diabetes

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; MICRORNA; MIRN128 MICRORNA, HUMAN; MIRN146 MICRORNA, HUMAN; MIRN27 MICRORNA, HUMAN;

AGED; COMPLICATION; DIABETIC CARDIOMYOPATHIES; DIABETIC NEUROPATHIES; FEMALE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; DIABETES MELLITUS, TYPE 2; DIABETIC CARDIOMYOPATHIES; DIABETIC NEUROPATHIES; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MICRORNAS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84905923828     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-014-0582-2     Document Type: Article

References (59)

1. Dyck PJ, Albers JW, Andersen H, Arezzo JC, Biessels GJ, Bril V, Feldman EL, Litchy WJ, O'Brien PC, Russell JW; on behalf of the Toronto Expert Panel on Diabetic Neuropathy* (2011) Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity. Diabetes Metab Res Rev doi:10.1002/dmrr.1226
2. Yagihashi S, Mizukami H, Sugimoto K (2011) Mechanism of diabetic neuropathy: where are we now and where to go? J Diabetes Invest 2(1):18-32
3. Fedele D, Comi G, Coscelli C, Cucinotta D, Feldman EL, Ghirlanda G, Greene DA, Negrin P, Santeusanio F (1997) A multicenter study on the prevalence of diabetic neuropathy in Italy. Italian diabetic neuropathy committee. Diabetes Care 20(5):836-843 (Pubitemid 27202538)
4. Várkonyi T, Kempler P (2008) Diabetic neuropathy: new strategies for treatment. Diabetes Obes Metab 10:99-108
5. Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P, Lauria G, Malik RA, Spallone V, Vinik A, Bernardi L, Valensi P; Toronto Diabetic Neuropathy Expert Group (2010) Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 33(10):2285-2293
6. Gries FA, Cameron NE, Low PA, Ziegler D (2003) Textbook of diabetic neuropathy. Thieme, Stuttgard, pp 64-82
7. Papanas N, Vinik AI, Ziegler D (2011) Neuropathy in prediabetes: does the clock start ticking early? Nat Rev Endocrinol 7:682-690
8. Spallone V, Bellavere F, Scionti L, Maule S, Quadri R, Bax G, Melga P, Viviani GL, Esposito K, Morganti R, Cortelli P; Diabetic Neuropathy Study Group of the Italian Society of Diabetology (2011) Recommendations for the use of cardiovascular tests in diagnosing diabetic autonomic neuropathy. Nutr Metab Cardiovasc Dis 21(1):69-78
9. Töyry JP, Partanen JV, Niskanen LK, Länsimies EA, Uusitupa MI (1997) Divergent development of autonomic and peripheral somatic neuropathies in NIDDM. Diabetologia 40(8):953-958 (Pubitemid 27316577)
10. Gaede P, Pedersen O (2004) Intensive integrated therapy of type 2 diabetes: implications for long-term prognosis. Diabetes 53(Suppl 3):S39-S47 (Pubitemid 39564521)
11. Jurado J, Ybarra J, Romeo JH, Garcia M, Zabaleta-Del-Olmo E (2012) Angiotensin-converting enzyme gene single polymorphism as a genetic biomarker of diabetic peripheral neuropathy: longitudinal prospective study. J Diabetes Complicat 26(2):77-82
12. Mansoor Q, Javaid A, Bilal N, Ismail M (2012) Angiotensinconverting enzyme (ACE) gene II genotype protects against the development of diabetic peripheral neuropathy in type 2 diabetes mellitus. J Diabetes 4(3):257-261
13. Yigit S, Karakus N, Inanir A (2013) Association of MTHFR gene C677T mutation with diabetic peripheral neuropathy and diabetic retinopathy. Mol Vis 19:1626-1630
14. Vojtková J, Ďurdík P, Čiljaková M, MichnováZ, Turčan T, Babušíková E (2013) The association between glutathione S-transferase T1 and M1 gene polymorphisms and cardiovascular autonomic neuropathy in Slovak adolescents with type 1 diabetes mellitus. J Diabetes Complicat 27(1):44-48
15. Karolina DS, Armugam A, Sepramaniam S (2012) MiRNAs and diabetes mellitus. Expert Rev Endocrinol Metab 7(3):281-300
16. Shantikumar S, Caporali A, Emanueli C (2012) Role of microRNAs in diabetes and its cardiovascular complications. Cardiovasc Res 93(4):583-593
17. Sun G, Yan J, Noltner K, Feng J, Li H, Sarkis DA, Sommer SS, Rossi JJ (2009) SNPs in human miRNA genes affect biogenesis and function. RNA 15(9):1640-1651
18. Ciccacci C, Di Fusco D, Cacciotti L, Morganti R, D'Amato C, Greco C, Rufini S, Novelli G, Sangiuolo F, Spallone V, Borgiani P (2013) MicroRNA genetic variations: association with type 2 diabetes. Acta Diabetol 50(6):867-872
19. Bril V, Perkins BA (2002) Validation of the Toronto clinical scoring system for diabetic polyneuropathy. Diabetes Care 25(11):2048-2052 (Pubitemid 41071067)
20. Bax G, Fagherazzi C, Piarulli F, Nicolucci A, Fedele D (1996) Reproducibility of Michigan neuropathy screening instrument (MNSI): a comparison with tests using the vibratory and thermal perception thresholds. Diabetes Care 19(8):904-905
21. Zinman LH, Bril V, Perkins BA (2004) Cooling detection thresholds in the assessment of diabetic sensory polyneuropathy: comparison of CASE IV and Medoc instruments. Diabetes Care 27(7):1674-1679 (Pubitemid 38857443)
22. Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, Bruxelle J, Cunin G, Fermanian J, Ginies P, Grun-Overdyking A, Jafari-Schluep H, Lantéri-Minet M, Laurent B, Mick G, Serrie A, Valade D, Vicaut E (2005) Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 114:29-36 (Pubitemid 40279084)
23. Spallone V, Morganti R, D'Amato C, Greco C, Cacciotti L, Marfia GA (2012) Validation of DN4 as a screening tool for neuropathic pain in painful diabetic polyneuropathy. Diabet Med 29:578-585
24. Stålberg E, Falck B, Gilai A, Jabre J, Sonoo M, Todnem K (1999) Standards for quantification of EMG and neurography. The international federation of clinical neurophysiology. Electroencephalogr Clin Neurophysiol Suppl 52:213-220
25. Dunnigan SK, Ebadi H, Breiner A, Katzberg HD, Lovblom LE, Perkins BA, Bril V (2013) Conduction slowing in diabetic sensorimotor polyneuropathy. Diabetes Care 36:3684-3690
26. Natarajan R, Putta S, Kato M (2012) MicroRNAs and diabetic complications. J Cardiovasc Transl Res 5(4):413-422
27. Lorenzen J, Kumarswamy R, Dangwal S, Thum T (2012) MicroRNAs in diabetes and diabetes-associated complications. RNA Biol 9(6):820-827
28. Kovacs B, Lumayag S, Cowan C, Xu S (2011) MicroRNAs in early diabetic retinopathy in streptozotocin-induced diabetic rats. Invest Ophthalmol Vis Sci 52(7):4402-4409
29. Feng B, Chen S, McArthur K, Wu Y, Sen S, Ding Q, Feldman RD, Chakrabarti S (2011) miR-146a-mediated extracellular matrix protein production in chronic diabetes complications. Diabetes 60(11):2975-2984
30. McArthur K, Feng B, Wu Y, Chen S, Chakrabarti S (2011) Micr-oRNA- 200b regulates vascular endothelial growth factor-mediated alterations in diabetic retinopathy. Diabetes 60(4):1314-1323
31. Silva VA, Polesskaya A, Sousa TA, Corrêa VM, André ND, Reis RI, Kettelhut IC, Harel-Bellan A, De Lucca FL (2011) Expression and cellular localization of microRNA-29b and RAX, an activator of the RNA-dependent protein kinase (PKR), in the retina of streptozotocin-induced diabetic rats. Mol Vis 17:2228-2240
32. Du B, Ma LM, Huang MB, Zhou H, Huang HL, Shao P, Chen YQ, Qu LH (2010) High glucose down-regulates miR-29a to increase collagen IV production in HK-2 cells. FEBS Lett 584(4):811-816
33. Srivastava K, Srivastava A (2012) Comprehensive review of genetic association studies and meta-analyses on miRNA polymorphisms and cancer risk. PLoS One 7(11):e50966
34. Wang PY, Gao ZH, Jiang ZH, Li XX, Jiang BF, Xie SY (2013) The associations of single nucleotide polymorphisms in miR- 146a, miR-196a and miR-499 with breast cancer susceptibility. PLoS One 8(9):e70656
35. Chen HF, Hu TT, Zheng XY, Li MQ, Luo MH, Yao YX, Chen Q, Yu SY (2013) Association between miR-146a rs2910164 polymorphism and autoimmune diseases susceptibility: a meta-analysis. Gene 521(2):259-264
36. Luo X, Yang W, Ye DQ, Cui H, Zhang Y, Hirankarn N, Qian X, Tang Y, Lau YL, de Vries N, Tak PP, Tsao BP, Shen N (2011) A functional variant in microRNA-146a promoter modulates its expression and confers disease risk for systemic lupus erythematosus. PLoS Genet 7(6):e1002128
37. Yang B, Zhang JL, Shi YY, Li DD, Chen J, Huang ZC, Cai B, Song XB, Li LX, Ying BW, Wang LL (2011) Association study of single nucleotide polymorphisms in pre-miRNA and rheumatoid arthritis in a Han Chinese population. Mol Biol Rep 38(8):4913-4919
38. Green MJ, Cairns MJ, Wu J, Dragovic M, Jablensky A, Tooney PA, Scott RJ, Carr VJ, Australian Schizophrenia Research Bank (2013) Genome-wide supported variant MIR137 and severe negative symptoms predict membership of an impaired cognitive subtype of schizophrenia. Mol Psychiatry 18(7):774-780
39. Tang Y, Luo X, Cui H, Ni X, Yuan M, Guo Y, Huang X, Zhou H, de Vries N, Tak PP, Chen S, Shen N (2009) MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthr Rheum 60:1065-1075
40. Li D, Wang T, Song X, Qucuo M, Yang B, Zhang J, Wang J, Ying B, Tao C, Wang L (2011) Genetic study of two single nucleotide polymorphisms within corresponding microRNAs and susceptibility to tuberculosis in a Chinese Tibetan and Han population. Hum Immunol 72(7):598-602
41. Jazdzewski K, Liyanarachchi S, Swierniak M, Pachucki J, Ringel MD, Jarzab B, de la Chapelle A (2009) Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer. Proc Natl Acad Sci USA 106(5):1502-1505
42. Balasubramanyam M, Aravind S, Gokulakrishnan K, Prabu P, Sathishkumar C, Ranjani H, Mohan V (2011) Impaired miR-146a expression links subclinical inflammation and insulin resistance in Type 2 diabetes. Mol Cell Biochem 351(1-2):197-205
43. Hou J, Wang P, Lin L, Liu X, Ma F, An H, Wang Z, Cao X (2009) MicroRNA-146a feedback inhibits RIG-I-dependent type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J Immunol 183:2150-2158
44. Bhaumik D, Scott GK, Schokrpur S, Patil CK, Campisi J, Benz CC (2008) Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells. Oncogene 27(42):5643-5647
45. Pauley KM, Satoh M, Chan AL, Bubb MR, Reeves WH, Chan EK (2008) Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthr Res Ther 10:R101
46. Ramkaran P, Khan S, Phulukdaree A, Moodley D, Chuturgoon AA (2013) miR-146a polymorphism influences levels of miR-146a, IRAK-1, and TRAF-6 in young patients with coronary artery disease. Cell Biochem Biophys. doi:10.1007/s12013-013-9704-7
47. Cameron NE, Cotter MA (2008) Pro-inflammatory mechanisms in diabetic neuropathy: focus on the nuclear factor kappa B pathway. Curr Drug Target 9(1):60-67 (Pubitemid 351209290)
48. Obrosova IG (2009) Diabetic painful and insensate neuropathy: pathogenesis and potential treatments. Neurotherapeutics 6(4):638-647
49. Herder C, Lankisch M, Ziegler D, Rathmann W, Koenig W, Illig T, Döring A, Thorand B, Holle R, Giani G, Martin S, Meisinger C (2009) Subclinical inflammation and diabetic polyneuropathy: MONICA/KORA survey F3 (Augsburg, Germany). Diabetes Care 32(4):680-682
50. Doupis J, Lyons TE, Wu S, Gnardellis C, Dinh T, Veves A (2009) Microvascular reactivity and inflammatory cytokines in painful and painless peripheral diabetic neuropathy. J Clin Endocrinol Metab 94(6):2157-2163
51. Spallone V, Greco C (2013) Painful and painless diabetic neuropathy: one disease or two? Curr Diabetes Rep 13(4):533-549
52. Sajadieh A, Nielsen OW, Rasmussen V, Hein HO, Abedini S, Hansen JF (2004) Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in mid-dle- aged and elderly subjects with no apparent heart disease. Eur Heart J 25(5):363-370 (Pubitemid 38391517)
53. Sloan RP, McCreath H, Tracey KJ, Sidney S, Liu K, Seeman T (2007) RR interval variability is inversely related to inflammatory markers: the CARDIA study. Mol Med 13(3-4):178-184 (Pubitemid 46944960)
54. Lanza GA, Pitocco D, Navarese EP, Sestito A, Sgueglia GA, Manto A, Infusino F, Musella T, Ghirlanda G, Crea F (2007) Association between cardiac autonomic dysfunction and inflammation in type 1 diabetic patients: effect of beta-blockade. Eur Heart J 28(7):814-820 (Pubitemid 47343595)
55. Lieb DC, Parson HK, Mamikunian G, Vinik AI (2012) Cardiac autonomic imbalance in newly diagnosed and established diabetes is associated with markers of adipose tissue inflammation. Exp Diabetes Res 2012:878760
56. Grant RW, Moore AF, Florez JC (2009) Genetic architecture of type 2 diabetes: recent progress and clinical implications. Diabetes Care 32(6):1107-1114
57. Motohashi N, Alexander MS, Shimizu-Motohashi Y, Myers JA, Kawahara G, Kunkel LM (2013) Regulation of IRS1/Akt insulin signaling by microRNA-128a during myogenesis. J Cell Sci 126(Pt 12):2678-2691
58. Guerau-de-Arellano M, Smith KM, Godlewski J, Liu Y, Winger R, Lawler SE, Whitacre CC, Racke MK, Lovett-Racke AE (2011) Micro-RNA dysregulation in multiple sclerosis favours proinflammatory T-cell-mediated autoimmunity. Brain 134(Pt 12):3578-3589
59. Narasimhan M, Patel D, Vedpathak D, Rathinam M, Henderson G, Mahimainathan L (2012) Identification of novel microRNAs in posttranscriptional control of Nrf2 expression and redox homeostasis in neuronal, SH-SY5Y cells. PLoS One 7(12):e51111